Vimarsana
Biggest News Aggregation in the World

Page 2 - Trvn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trvn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trvn Today - Breaking & Trending Today

Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report published on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Trevena Stock Performance NASDAQ:TRVN opened at $0.64 on Thursday. Trevena has a 1-year low of $0.51 and a 1-year high of $3.28. The company has a debt-to-equity […]

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com - Vimarsana News

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a note issued to investors on Wednesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Trevena Price Performance TRVN stock opened at $0.69 on Wednesday. Trevena has a 1 year low of $0.51 and a 1 […]

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com - Vimarsana News

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report released on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Trevena Price Performance TRVN opened at $0.73 on Monday. Trevena has a 1-year low of $0.51 and a 1-year high of $3.28. The company has a current […]

Source: wkrb13.com
Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report sent to investors on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Trevena Stock Performance NASDAQ:TRVN opened at $0.72 on Monday. The company has a debt-to-equity ratio of 8.35, a quick ratio of 6.27 and […]

Trevena, Inc. (NASDAQ:TRVN) Sees Significant Decrease in Short Interest - Vimarsana News

Trevena, Inc. (NASDAQ:TRVN) Sees Significant Decrease in Short Interest

Trevena, Inc. (NASDAQ:TRVN – Get Free Report) saw a large decrease in short interest in December. As of December 15th, there was short interest totalling 286,800 shares, a decrease of 41.8% from the November 30th total of 493,000 shares. Based on an average daily volume of 334,300 shares, the short-interest ratio is currently 0.9 days. […]